Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Clinical trial NCT05476770 · RECRUITING

Trial details

NCT number: NCT05476770
Sponsor: Therapeutic Advances in Childhood Leukemia Consortium
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hematologic Malignancy AML ALL BPDCN MDS Lymphoblastic Lymphoma Lymphoma, B-Cell Lymphoma, T-Cell Hodgkin Lymphoma Mixed Phenotype Acute Leukemia Acute Undifferentiated Leukemia

Start date: 2022-11-11
Primary completion: 2025-11-11
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.